Testing Status of Isophosphamide C01638
CASRN: 3778-73-2
Formula: C7-H15-Cl2-N2-O2-P
Synonyms/Common Names
- N,3-Bis(2-chloroethyl)tetrahydro-2H,1,3,2-oxazaphospharin-2-amine,2-oxide (9CI)
Short-Term Toxicity
- 14-Day (Intraperitoneal Injection)
(C01638)
Completed
- Rats: Sprague Dawley; Mice: B6C3F1
- 13-Week (Intraperitoneal Injection)
(C01638)
Completed
- Rats: Sprague Dawley; Mice: B6C3F1
- Dose: MR: 0, 2.4, 48, MM: 0, 4, 80 MG/KG/5 PER GROUP.
Long-Term Carcinogenicity
- 2-Year (Intraperitoneal Injection)
(C01638)
Completed
- TR-032 (NIH Number: 77-832)
(Peer Review Approval 09/26/1977A )
Bioassay of Isophosphamide for Possible Carcinogenicity (CASRN 3778-73-2) - Rats: Sprague Dawley; Mice: B6C3F1
- Carcinogenesis Results
- Male Rats Negative
- Female Rats Positive
- Male Mice Negative
- Female Mice Positive
- Dose: R: 0, 6, 12, M: 0, 10, 20 MG/KG/35 PER GROUP.
- TR-032 (NIH Number: 77-832)
(Peer Review Approval 09/26/1977A )